HK2 and non-small cell lung carcinoma: Our evaluation of the differences in the expression levels revealed a significantly higher expression of MCT1 and HK2 (p = 0.005 and p = 0.015, respectively) in the CTC fraction between HD and early stage NSCLC patients, whereas no statistically significant difference was observed for PHGDH (Figure 3).